Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy
Authors:
- Roberto PersianiRPRoberto Persiani
- Domenico D'UgoDDDomenico D'Ugo
- Carmelo PozzoCPCarmelo Pozzo
- Giuseppe La TorreGiuseppe La Torre
- Aurelio PicciocchiAPAurelio Picciocchi
- 22 February 2005
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 89 (4) , 227-236
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Gastic cancerThe Lancet, 2003
- The epidemiology of gastric cancerSeminars in Radiation Oncology, 2002
- The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomyCancer, 2000
- Magentumoren2000
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Preoperative and Postoperative Combination Chemotherapy for Potentially Resectable Gastric CarcinomaJNCI: Journal of the National Cancer Institute, 1993
- Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992Cancer, 1993
- Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracilBritish Journal of Surgery, 1991
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- Gastric cancer: A 25-year reviewBritish Journal of Surgery, 1989